Literature DB >> 9314985

Hippocampal transverse relaxation times in patients with Alzheimer disease.

N G Campeau1, R C Petersen, J P Felmlee, P C O'Brien, C R Jack.   

Abstract

PURPOSE: To determine whether hippocampal relaxation times in magnetic resonance (MR) imaging differ between patients with probable Alzheimer disease and elderly control subjects with normal cognition.
MATERIALS AND METHODS: MR imaging relaxation times were measured in the head and body of the right and left hippocampi in 123 subjects: 62 patients with Alzheimer disease (44 women, 18 men; age range, 65-89 years) and 61 elderly control subjects without cognitive impairment (39 women, 22 men; age range, 65-89 years). Hippocampal relaxation times were correlated with clinical status (patient vs control subject), age, sex, laterality (right vs left), and location within the hippocampus (body vs head). The hippocampal T2 value was correlated with the severity of disease in the patients.
RESULTS: No statistically significant difference in the relaxation times was found between the two clinical groups for the analysis of the right versus left hippocampi and the hippocampal head versus body. In both patients and control subjects, no correlation was found between T2 measurements and age or sex. Twenty-seven patients had a clinical dementia rating (CDR) score of 0.5 (very mild dementia), 21 patients had a CDR score of 1.0 (mild dementia), and eight patients had a CDR score of 2.0 (moderate dementia). The CDR score was not available in six patients. No statistically significant association between T2 values and severity of disease was observed.
CONCLUSION: MR relaxation time measurements in the hippocampus are not useful for the detection of Alzheimer disease.

Entities:  

Mesh:

Year:  1997        PMID: 9314985     DOI: 10.1148/radiology.205.1.9314985

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

Authors:  H Hanyu; T Asano; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  Sodium MR imaging detection of mild Alzheimer disease: preliminary study.

Authors:  E A Mellon; D T Pilkinton; C M Clark; M A Elliott; W R Witschey; A Borthakur; R Reddy
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-12       Impact factor: 3.825

3.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.

Authors:  C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

4.  High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron.

Authors:  Vijay Antharam; Joanna F Collingwood; John-Paul Bullivant; Mark R Davidson; Saurav Chandra; Albina Mikhaylova; Mary E Finnegan; Christopher Batich; John R Forder; Jon Dobson
Journal:  Neuroimage       Date:  2011-08-16       Impact factor: 6.556

5.  In vivo measurement of plaque burden in a mouse model of Alzheimer's disease.

Authors:  Arijitt Borthakur; Tamar Gur; Andrew J Wheaton; Matthew Corbo; John Q Trojanowski; Virginia M-Y Lee; Ravinder Reddy
Journal:  J Magn Reson Imaging       Date:  2006-11       Impact factor: 4.813

6.  T(1ρ) MRI in Alzheimer's disease: detection of pathological changes in medial temporal lobe.

Authors:  Mohammad Haris; Anup Singh; Kejia Cai; Erin McArdle; Matthew Fenty; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

7.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

8.  Early marker for Alzheimer's disease: hippocampus T1rho (T(1rho)) estimation.

Authors:  Mohammad Haris; Erin McArdle; Matthew Fenty; Anup Singh; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur
Journal:  J Magn Reson Imaging       Date:  2009-05       Impact factor: 4.813

9.  Hippocampal volume reduction in elderly patients at risk for postoperative cognitive dysfunction.

Authors:  Ming-hua Chen; Yan Liao; Peng-fei Rong; Rong Hu; Guo-xin Lin; Wen Ouyang
Journal:  J Anesth       Date:  2013-01-31       Impact factor: 2.078

10.  Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss.

Authors:  M J House; T G St Pierre; J K Foster; R N Martins; R Clarnette
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.